Avant Devices Moves Toward Electric Wheelchair Kit Production with New Funding Drive

Murcia-based startup Avant Devices is preparing for the next major step in its development: the mass production of its innovative kit designed to transform traditional manual wheelchairs into electric mobility solutions.

The company expects to begin manufacturing as early as the beginning of next year, but first needs additional funding to complete certification, scale operations, and bring the product to market.

Crowdfunding Campaign Supports Certification and Market Launch

To achieve this goal, Avant Devices has launched a crowdfunding campaign through StartupXplore, seeking to raise up to €260,000 from individual investors. The funds will support key areas of the business, including obtaining official product certification, creating a dedicated sales team, and producing the first commercial units.

“We want to use this round to achieve product certification, develop a sales structure, and manufacture the first units,” explained Juan Antonio Carrasco, CEO and founder of Avant Devices, in an interview.

The campaign has already received €50,000 in commitments before its official crowdfunding phase and aims to secure at least another €10,000 to reach the platform’s minimum target of €60,000. Investors will have three weeks to participate in the funding round.

Looking ahead, the company estimates that the certification process will take approximately six to seven months. If timelines remain on track, Avant Devices could begin production around March or April, with projected revenues of approximately €400,000 during 2027.

Avant Devices Has Closed Strategic Partnerships to Accelerate Growth

The startup is also strengthening its market position through strategic partnerships. It has signed agreements with the D’Genes Association and the Ibero-American Alliance for Rare, Orphan, or Uncommon Diseases (ALIBER). These collaborations are expected to improve access to potential customers and expand awareness of the product among people with mobility challenges. The company is also exploring additional partnerships with other Spanish organizations.

Avant Devices has already developed a functional prototype that has undergone testing in diverse environments, including urban areas, beaches, and mountainous terrain. According to Carrasco, the project is currently in the pre-industrialization stage and must still complete the transition toward full industrial manufacturing.

Once production is scaled, the company plans to expand internationally. Carrasco believes that its partnership with ALIBER could help open opportunities in Latin America, supporting Avant Devices’ ambition to bring its electric wheelchair technology to a wider global audience.

__

(Featured image by Jon Tyson via Unsplash)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in murciaplaza. A third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.